The store will not work correctly when cookies are disabled.
5-(2,4-dimethylphenylsulfonamido)-2-methylbenzofuran-3-carboxylic acid
ID: ALA4787643
PubChem CID: 7312249
Max Phase: Preclinical
Molecular Formula: C18H17NO5S
Molecular Weight: 359.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(S(=O)(=O)Nc2ccc3oc(C)c(C(=O)O)c3c2)c(C)c1
Standard InChI: InChI=1S/C18H17NO5S/c1-10-4-7-16(11(2)8-10)25(22,23)19-13-5-6-15-14(9-13)17(18(20)21)12(3)24-15/h4-9,19H,1-3H3,(H,20,21)
Standard InChI Key: FSHWCROCQKCHCS-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
12.4436 -10.3635 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0391 -9.6577 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.6302 -10.3609 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9163 -8.4319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9152 -9.2514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6232 -9.6604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3329 -9.2510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3300 -8.4283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6214 -8.0230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7483 -9.2487 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4566 -9.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4533 -10.4719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1608 -10.8793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1569 -9.2444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8649 -9.6481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8719 -10.4666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6526 -10.7129 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.1281 -10.0466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6412 -9.3886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8891 -8.6068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6870 -8.4301 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.3371 -8.0043 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.9452 -10.0396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6230 -10.4776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2085 -8.0235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
7 2 1 0
2 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 16 2 0
15 14 2 0
14 11 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 15 1 0
20 21 1 0
20 22 2 0
19 20 1 0
18 23 1 0
6 24 1 0
4 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 359.40 | Molecular Weight (Monoisotopic): 359.0827 | AlogP: 3.86 | #Rotatable Bonds: 4 |
Polar Surface Area: 96.61 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.12 | CX Basic pKa: ┄ | CX LogP: 3.50 | CX LogD: 0.34 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.74 | Np Likeness Score: -1.49 |
References
1. Hou X,Sun JP,Ge L,Liang X,Li K,Zhang Y,Fang H. (2020) Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets., 190 [PMID:32078861] [10.1016/j.ejmech.2020.112131] |